Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
12/2003
12/09/2003CA1341449C Poly-kringle plasminogen activator
12/06/2003CA2431349A1 Method of producing a recombinant virus
12/04/2003WO2003100557A2 Computer systems and methods for subdividing a complex disease into component diseases
12/04/2003WO2003100541A2 Methods for profiling molecules with an objective function
12/04/2003WO2003100438A1 Assays for modulators of asparaginyl hydroxylase
12/04/2003WO2003100437A1 Method for identifying type-i interferon responsive ms patients by determining trail expression
12/04/2003WO2003100435A2 Diagnostics and therapeutic use of neuromedin u receptor 2 (nmu2)
12/04/2003WO2003100432A2 Method for identifying immunoreactive peptides
12/04/2003WO2003100101A1 Methods and apparati using single polymer analysis
12/04/2003WO2003100099A1 Parallel stranded duplexes of deoxyribonucleic acid and methods of use
12/04/2003WO2003100096A1 Application of cantilevers in nucleic acid sequencing
12/04/2003WO2003100093A2 Method of selecting targets for gene silencing by rna interference
12/04/2003WO2003100090A2 Protein c polymorphisms
12/04/2003WO2003100087A2 Regulation of novel human asparagine-hydroxylases
12/04/2003WO2003100074A2 Animal genotyping method
12/04/2003WO2003100072A2 Method for the production of sulphur-containing fine chemicals by fermentation
12/04/2003WO2003100070A2 The frog prince, a transposon vector for gene transfer in vertebrates
12/04/2003WO2003100069A1 Method for transferring molecules in vital cells by means of laser beams and arrangement for carrying out said method
12/04/2003WO2003100068A1 Reporter system for plants
12/04/2003WO2003100067A1 Plant tissue-specific promoter forming secondary walls
12/04/2003WO2003100066A1 A method for production of plants with suppressed photorespiration and improved co2 fixation
12/04/2003WO2003100064A1 Novel ubiquitin ligase
12/04/2003WO2003100063A1 A repressor-mediated regulation system for control of gene expression in plants
12/04/2003WO2003100062A1 Ehd1 GENE PROMOTING PLANT FLOEWERING AND UTILIZATION THEREOF
12/04/2003WO2003100061A2 Three finger toxin fold proteins
12/04/2003WO2003100060A2 Muc-1 antigen with reduced number of vntr repeat units
12/04/2003WO2003100059A2 Molecular targeting of the igf-1 receptor
12/04/2003WO2003100058A2 Method for creating polynucleotide molecules
12/04/2003WO2003100056A1 Novel polyphosphate:amp phosphotransferase
12/04/2003WO2003100054A1 Regulation of the formation of plant phragmoplast and method of constructing male sterile plant
12/04/2003WO2003100050A1 Hydantoin racemase
12/04/2003WO2003100049A1 Regulation of human rhomboid-related protein
12/04/2003WO2003100047A1 Cloning, expression and characterisation of the total sequence of phosphodiesterase 8b
12/04/2003WO2003100045A1 Plant thymidine kinases and their use
12/04/2003WO2003100042A1 Method for assembling sub units into capsoides
12/04/2003WO2003100040A1 A method for generating antigen-presenting cells
12/04/2003WO2003100033A2 ANTI-αvβ6 ANTIBODIES
12/04/2003WO2003100032A2 Dwarfism genes and dwarf plants
12/04/2003WO2003100028A2 Tr2, tr4, tr2/tr4 double knockouts and uses thereof
12/04/2003WO2003100022A2 Methods and dna constructs for high yield production of polypeptides
12/04/2003WO2003100021A2 Methods and dna constructs for high yield production of polypeptides
12/04/2003WO2003100020A2 Methods and constructs for high yield expression of clostripain
12/04/2003WO2003100018A2 A bank of stem cells for transplantation
12/04/2003WO2003100017A2 Oligonucleotides having modified nucleoside units
12/04/2003WO2003100015A2 Polypeptide cleavage process
12/04/2003WO2003100012A2 Microarrays and method for running hybridization reaction for multiple samples on a single microarray
12/04/2003WO2003100011A2 Generation of histocompatible tissues using nuclear transplantation
12/04/2003WO2003100008A2 Neutralizing human anti-igfr antibody
12/04/2003WO2003100001A2 Claudin polypeptides, polynucleotides, and methods of making and use thereof
12/04/2003WO2003100000A2 Amplification and overexpression of oncogenes
12/04/2003WO2003099999A2 Generation and selection of protein library in silico
12/04/2003WO2003099997A2 Methods and compositions for regulation and manipulation of steroidogenesis
12/04/2003WO2003099996A2 Detection of secreted polypeptides
12/04/2003WO2003099995A2 Murine ortholog of the human disrupted-in-schizophrenia 1 gene
12/04/2003WO2003099990A2 Compositions and methods for cloning nucleic acids
12/04/2003WO2003099869A1 Antibody capable of recognizing 8-nitroguanine
12/04/2003WO2003099866A1 Transformed fungi for production of recombinant proteins
12/04/2003WO2003099865A1 Cation channel proteins
12/04/2003WO2003099860A2 Immunogenic composition and peptide sequences for prevention and treatment of an hsv condition
12/04/2003WO2003099859A2 Novel use of adenoviruses and nucleic acids coding therefor
12/04/2003WO2003099853A2 Petide amidation process
12/04/2003WO2003099842A2 Compositions and methods of use for a bombesin peptide
12/04/2003WO2003099839A1 Modulators and inhibitors of fibroblast growth factor receptor 5_polypeptides and gene expression thereof.
12/04/2003WO2003099830A2 Cardiolipin compositions, methods of preparation and use
12/04/2003WO2003099781A2 METHODS FOR THE IDENTIFICATION OF IKKα FUNCTION AND OTHER GENES USEFUL FOR TREATMENT OF INFLAMMATORY DISEASES
12/04/2003WO2003099779A2 Hemipteran muscarinic receptor
12/04/2003WO2003099340A1 Novel chimeric cd154
12/04/2003WO2003099339A1 Decoy composition for treating and preventing inflammatory disease
12/04/2003WO2003099331A1 Insulin resistance improving agents
12/04/2003WO2003099321A1 Methods for preventing, treating or delaying cardiac toxicity using neuregulin
12/04/2003WO2003099320A1 Neuregulin based methods and compositions for treating viral myocarditis and dilated cardiomyopathy
12/04/2003WO2003099318A2 Pancreas-specific proteins
12/04/2003WO2003099300A1 Neuregulin based methods and compositions for treating cardiovascular diseases
12/04/2003WO2003099299A1 Agents and methods for the treatment of disorders associated with motor neuron degeneration
12/04/2003WO2003099298A1 Rna interference mediating small rna molecules
12/04/2003WO2003099233A2 Microbial conversion of glucose to para-hydroxystyrene
12/04/2003WO2003099228A2 Compositions and processes for inhibiting gene expression using polynucleotides
12/04/2003WO2003099227A2 Modulation of ptp1b signal transduction by rna interference
12/04/2003WO2003099225A2 Compositions for delivering nucleic acids to cells
12/04/2003WO2003099224A2 Antisense moodulation of kinesin-like 1 expression
12/04/2003WO2003099219A2 Bryostatins, bryopyrans and polyketides: compositions and methods
12/04/2003WO2003099216A2 Fatty acid desaturases from fungi
12/04/2003WO2003099215A2 Antisense modulation of glucocorticoid receptor expression
12/04/2003WO2003099213A2 Method for reducing platelet count
12/04/2003WO2003099209A2 Compositions and methods for screening and identifying anti-hcv agents
12/04/2003WO2003099204A2 Antisense modulation of inhibitor-kappa b kinase-beta expression
12/04/2003WO2003099201A2 Compositions and methods of use for a fibroblast growth factor
12/04/2003WO2003099193A2 Vaccines
12/04/2003WO2003099003A1 Adiponectin-knoucout nonhuman animal
12/04/2003WO2003099002A1 Cathepsin-associaged genetically modified nonhuman mammal
12/04/2003WO2003099001A1 Nuclear transfer nuclei from histone hypomethylated donor cells
12/04/2003WO2003087356A3 Helicokinin-receptor from insects
12/04/2003WO2003082196A3 Combination therapy using trefoil peptides
12/04/2003WO2003080841A8 Calcineurin activators
12/04/2003WO2003079667A9 Improved nucleic acid amplification
12/04/2003WO2003078626A3 A building block capable of transferring a functional entity
12/04/2003WO2003078570A9 Multiple controls for molecular genetic analyses
12/04/2003WO2003075838A3 Methods and compositions for pharmacological and toxicological evaluation of test agents
12/04/2003WO2003072771A3 Method of preparing a treatment product using a togaviridae expression construct
12/04/2003WO2003072736A3 Reagents and treatment methods for autoimmune diseases
1 ... 2358 2359 2360 2361 2362 2363 2364 2365 2366 2367 2368 2369 2370 2371 2372 2373 2374 2375 2376 2377 2378 ... 4023